Michelle Rheault
Pediatric Nephrology · Minneapolis, MNNPI 1013053982
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,486 of the $16,856 with a category attached, or 74.1%. 6 manufacturers reported payments, led by Otsuka Pharmaceutical Development & Commercialization, Inc. at 59.2% of the total. Reporting peaked in 2024 at $7,932 and has fallen 62.0% since, to $3,018 in 2025.
Across 26 payments — averaging $648.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$10K
- Travere Therapeutics, Inc.$3K
- Kaneka Medical America LLC$2K
- Otsuka Pharmaceutical Co., Ltd.$2K
- AstraZeneca$150
- Calliditas Therapeutics US Inc.$107
Across 73 payments — averaging $6613.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Travere Therapeutics, Inc.$209K
- Novartis$116K
- Aurinia Pharma U.S., Inc.$86K
- Sanofi$54K
- Genentech, Inc.$11K
- Kaneka Medical America LLC$7K
What the payments were for
- Consulting fees$12,48674%
- Speaking & faculty fees$2,44915%
- Travel & lodging$1,1687%
- Food & beverage$7524%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 13 | $9,972 |
| Travere Therapeutics, Inc. | 9 | $2,578 |
| Kaneka Medical America LLC | 1 | $2,299 |
| Otsuka Pharmaceutical Co., Ltd. | 1 | $1,750 |
| AstraZeneca | 1 | $150 |
| Calliditas Therapeutics US Inc. | 1 | $107 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIPOSORBER$2,299
- ULTOMIRIS$150
- TARPEYO$107
How this compares
Too few pediatric nephrology providers in Minnesotato place this figure against a meaningful peer group, so we don't.
Other pediatric nephrology in Minneapolis
- Sheldon MauerMinneapolis$103K
- Clifford KashtanMinneapolis$1K
- Scott McEwenMinneapolis$225
- Shanthi BalaniMinneapolis$105
- Anne KouriMinneapolis$85
- Avi KatzMinneapolis$8
- David SasRochester$27K
- Christian HannaRochester$16K
- Jennifer NhanMaple Grove$133
- Cheryl TranRochester$15
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.